Literature DB >> 25807998

PfSR1 controls alternative splicing and steady-state RNA levels in Plasmodium falciparum through preferential recognition of specific RNA motifs.

Shiri Eshar1, Lindsey Altenhofen2,3, Alona Rabner4, Phil Ross3, Yair Fastman1, Yael Mandel-Gutfreund4, Rotem Karni5, Manuel Llinás2,3, Ron Dzikowski1.   

Abstract

Plasmodium species have evolved complex biology to adapt to different hosts and changing environments throughout their life cycle. Remarkably, these adaptations are achieved by a relatively small genome. One way by which the parasite expands its proteome is through alternative splicing (AS). We recently identified PfSR1 as a bona fide Ser/Arg-rich (SR) protein that shuttles between the nucleus and cytoplasm and regulates AS in Plasmodium falciparum. Here we show that PfSR1 is localized adjacent to the Nuclear Pore Complex (NPC) clusters in the nucleus of early stage parasites. To identify the endogenous RNA targets of PfSR1, we adapted an inducible overexpression system for tagged PfSR1 and performed RNA immunoprecipitation followed by microarray analysis (RIP-chip) to recover and identify the endogenous RNA targets that bind PfSR1. Bioinformatic analysis of these RNAs revealed common sequence motifs potentially recognized by PfSR1. RNA-EMSAs show that PfSR1 preferentially binds RNA molecules containing these motifs. Interestingly, we find that PfSR1 not only regulates AS but also the steady-state levels of mRNAs containing these motifs in vivo.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25807998     DOI: 10.1111/mmi.13007

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  11 in total

Review 1.  The Role of Chromatin Structure in Gene Regulation of the Human Malaria Parasite.

Authors:  Gayani Batugedara; Xueqing M Lu; Evelien M Bunnik; Karine G Le Roch
Journal:  Trends Parasitol       Date:  2017-01-05

Review 2.  Emerging biology of noncoding RNAs in malaria parasites.

Authors:  Karina Simantov; Manish Goyal; Ron Dzikowski
Journal:  PLoS Pathog       Date:  2022-07-07       Impact factor: 7.464

Review 3.  Unraveling the 3D genome of human malaria parasites.

Authors:  Gayani Batugedara; Karine G Le Roch
Journal:  Semin Cell Dev Biol       Date:  2018-07-27       Impact factor: 7.727

Review 4.  Translational regulation in blood stages of the malaria parasite Plasmodium spp.: systems-wide studies pave the way.

Authors:  Shruthi Sridhar Vembar; Dorothea Droll; Artur Scherf
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-05-26       Impact factor: 9.957

Review 5.  Alternative Splicing in Apicomplexan Parasites.

Authors:  Lee M Yeoh; V Vern Lee; Geoffrey I McFadden; Stuart A Ralph
Journal:  mBio       Date:  2019-02-19       Impact factor: 7.867

6.  The chromatin bound proteome of the human malaria parasite.

Authors:  Gayani Batugedara; Xueqing M Lu; Anita Saraf; Mihaela E Sardiu; Anthony Cort; Steven Abel; Jacques Prudhomme; Michael P Washburn; Laurence Florens; Evelien M Bunnik; Karine G Le Roch
Journal:  Microb Genom       Date:  2020-02-04

7.  Roles and Cellular Localization of GBP2 and NAB2 During the Blood Stage of Malaria Parasites.

Authors:  Mamoru Niikura; Toshiyuki Fukutomi; Jiro Mitobe; Fumie Kobayashi
Journal:  Front Cell Infect Microbiol       Date:  2021-09-15       Impact factor: 5.293

8.  PfAlba1: master regulator of translation in the malaria parasite.

Authors:  Evelien M Bunnik; Karine G Le Roch
Journal:  Genome Biol       Date:  2015-10-08       Impact factor: 13.583

9.  The mRNA-bound proteome of the human malaria parasite Plasmodium falciparum.

Authors:  Evelien M Bunnik; Gayani Batugedara; Anita Saraf; Jacques Prudhomme; Laurence Florens; Karine G Le Roch
Journal:  Genome Biol       Date:  2016-07-05       Impact factor: 13.583

Review 10.  malERA: An updated research agenda for basic science and enabling technologies in malaria elimination and eradication.

Authors: 
Journal:  PLoS Med       Date:  2017-11-30       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.